Natazia - A New Oral Contraceptive
The FDA has approved the marketing of Natazia (Bayer), a 4-phase oral contraceptive containing the
estrogen estradiol valerate and the progestin dienogest, both used for the first time in the US for this
indication....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Natazia - A New Oral Contraceptive
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1346
Article Code: 1346d
Date: September 6, 2010
Volume: 52
Pages: 71-72
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1346
Article Code: 1346d
Date: September 6, 2010
Volume: 52
Pages: 71-72
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)
